Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Current Opinion in Molecular Therapeutics
|
November 22, 2001
Progress towards a synthetic virus for systemic gene therapy
I MacLachlan, P Cullis, R W Graham
Current Opinion in Molecular Therapeutics
|
May 8, 2001
Long-circulating vectors for the systemic delivery of genes
D B Fenske, I MacLachlan, P R Cullis
Gene Therapy
|
January 23, 2004
An enhanced autogene-based dual-promoter cytoplasmic expression system yields increased gene expression
J Finn, A C H Lee, I MacLachlan, et al.
The Journal of Nutrition
|
May 1, 1995
Characterization of the Japanese quail oocyte receptor for very low density lipoprotein and vitellogenin
R G Elkin, I MacLachlan, M Hermann, et al.
Journal of Virology
|
April 1, 1997
Distinct domains of IkappaB-alpha inhibit human immunodeficiency virus type 1 replication through NF-kappaB and Rev
B Y Wu, C Woffendin, I MacLachlan, et al.
The Journal of Biological Chemistry
|
November 5, 1993
Riboflavinuria in the rd chicken. 5'-splice site mutation in the gene for riboflavin-binding protein
I MacLachlan, J Nimpf, H B White, et al.
The Biochemical Journal
|
July 15, 1996
Molecular characterization of quail apolipoprotein very-low-density lipoprotein II: disulphide-bond-mediated dimerization is not essential for inhibition of lipoprotein lipase
I MacLachlan, E Steyrer, A Hermetter, et al.
Biochimica Et Biophysica Acta
|
May 17, 2005
Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression
E Ambegia, S Ansell, P Cullis, et al.
Gene Therapy
|
August 6, 1999
Cationic lipid-mediated transfection of cells in culture requires mitotic activity
I Mortimer, P Tam, I MacLachlan, et al.
Gene Therapy
|
August 6, 1999
Stabilized plasmid-lipid particles: construction and characterization
J J Wheeler, L Palmer, M Ossanlou, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Current Opinion in Molecular Therapeutics
|
November 22, 2001
Progress towards a synthetic virus for systemic gene therapy
I MacLachlan, P Cullis, R W Graham
Current Opinion in Molecular Therapeutics
|
May 8, 2001
Long-circulating vectors for the systemic delivery of genes
D B Fenske, I MacLachlan, P R Cullis
Gene Therapy
|
January 23, 2004
An enhanced autogene-based dual-promoter cytoplasmic expression system yields increased gene expression
J Finn, A C H Lee, I MacLachlan, et al.
The Journal of Nutrition
|
May 1, 1995
Characterization of the Japanese quail oocyte receptor for very low density lipoprotein and vitellogenin
R G Elkin, I MacLachlan, M Hermann, et al.
Journal of Virology
|
April 1, 1997
Distinct domains of IkappaB-alpha inhibit human immunodeficiency virus type 1 replication through NF-kappaB and Rev
B Y Wu, C Woffendin, I MacLachlan, et al.
The Journal of Biological Chemistry
|
November 5, 1993
Riboflavinuria in the rd chicken. 5'-splice site mutation in the gene for riboflavin-binding protein
I MacLachlan, J Nimpf, H B White, et al.
The Biochemical Journal
|
July 15, 1996
Molecular characterization of quail apolipoprotein very-low-density lipoprotein II: disulphide-bond-mediated dimerization is not essential for inhibition of lipoprotein lipase
I MacLachlan, E Steyrer, A Hermetter, et al.
Biochimica Et Biophysica Acta
|
May 17, 2005
Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression
E Ambegia, S Ansell, P Cullis, et al.
Gene Therapy
|
August 6, 1999
Cationic lipid-mediated transfection of cells in culture requires mitotic activity
I Mortimer, P Tam, I MacLachlan, et al.
Gene Therapy
|
August 6, 1999
Stabilized plasmid-lipid particles: construction and characterization
J J Wheeler, L Palmer, M Ossanlou, et al.
Page
of 2